GGrantIndex
← Search

Clinical Protocol and Data Management

$336,019P30FY2019CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

The overall goal of the Clinical Protocol and Data Management (CPDM) resource at Roswell Park is to assist investigators in the development, implementation, conduct, completion, and reporting of clinical trials in a scientifically rigorous and regulatory compliant manner. This goal is carried out by the Clinical Research Services, a centralized resource that oversees a broad portfolio of clinical trials, including institutional trials (investigator-initiated or IIT), national clinical trial network, other NCI-sponsored trials, and industry-sponsored trials. CRS provides infrastructure for all clinical research activities. CPDM staff assist investigators in assembling clinical and scientific content of protocols and developing budgets, as well as facilitating timely and effective protocol review and implementation. CPDM oversight of clinical research studies includes submission of the protocol, amendments, and continuing reviews to the Scientific Review Committee and the Institutional Review Board, and the management and tracking of all regulatory documents. CPDM staff provides administrative support to the Clinical Disease Teams for protocol prioritization and ongoing scientific relevance and the Data Safety Monitoring Committee. CPDM staff assist investigators in documentation of adverse events, outcomes, informed consent, accrual, and data items critical for safeguarding human subjects. CPDM ensures complete and accurate study data by entering the data in a centralized electronic research database. CPDM ensures that all adverse events and their attributions are reported promptly and accurately to the required internal and external regulatory agencies, and provides study sponsors and regulatory agencies with all required study documents. The CPDM has four specific aims: 1. Provide a central infrastructure including a clinical trial management system and technical staff to support Roswell Park investigators in their efforts to promote efficient and effective clinical trial development, activation, and outcome reporting. 2. Ensure clinical research performance in accordance with applicable regulations, policies, and procedures by providing training, and education. 3. Provide appropriate oversight and monitoring of all cancer-related Roswell Park clinical trials, ensuring participant safety, validity and integrity of the data collected, and quality control. 4. Coordinate and cultivate partnerships to promote and facilitate access and implementation of clinical trials within the Roswell Park catchment area, state of New York, and beyond.

View original record on NIH RePORTER →